Wolbachia :: drug effects
Latest Paper:
Department of Zoology, South Parks Road, University of Oxford, Oxford, OX1 3PS, UK. nathan.pike.1998@pem.cam.ac.uk
BACKGROUND: Wolbachia is an extremely widespread bacterial endosymbiont of arthropods and nematodes that causes a variety of reproductive peculiarities. Parthenogenesis is one such peculiarity but it has been hypothesised that this phenomenon may be functionally restricted to organisms that employ haplodiploid sex determination. Using two antibiotics, tetracycline and rifampicin, we attempted to eliminate Wolbachia from the diplodiploid host Folsomia candida, a species of springtail which is a widely used study organism. RESULTS: Molecular assays confirmed that elimination of Wolbachia was successfully achieved through continuous exposure of populations (over two generations and several weeks) to rifampicin administered as 2.7% dry weight of their yeast food source. The consequence of this elimination was total sterility of all individuals, despite the continuation of normal egg production. CONCLUSION: Microbial endosymbionts play an obligatory role in the reproduction of their diplodiploid host, most likely one in which the parthenogenetic process is facilitated by Wolbachia. A hitherto unknown level of host-parasite interdependence is thus recorded.
Mesh-terms: Animals; Anti-Bacterial Agents :: pharmacology; Arthropods :: chemistry; Arthropods :: microbiology; Arthropods :: physiology; Cloning, Organism; Clutch Size :: drug effects; Denmark; Diet; Diploidy; Female; France; Great Britain; Male; Ovum :: drug effects; Parthenogenesis; Polymerase Chain Reaction; Reproduction :: drug effects; Rifampin :: pharmacology; Symbiosis :: drug effects; Tetracycline :: pharmacology; Wolbachia :: chemistry; Wolbachia :: drug effects; Wolbachia :: physiology;
Most cited papers:
Mesh-terms: Animals; Anti-Bacterial Agents :: pharmacology; Anti-Bacterial Agents :: therapeutic use; Brugia malayi :: drug effects; Brugia malayi :: microbiology; Filariasis :: drug therapy; Filariasis :: microbiology; Filariasis :: parasitology; Filarioidea :: drug effects; Filarioidea :: microbiology; Human; Onchocerca volvulus :: drug effects; Onchocerca volvulus :: microbiology; Rifampin :: therapeutic use; Symbiosis; Tetracycline :: pharmacology; Tetracycline :: therapeutic use; Wolbachia :: drug effects; Wolbachia :: pathogenicity; Wuchereria bancrofti :: drug effects; Wuchereria bancrofti :: microbiology;
Endosymbiotic bacteria living in plasmodia or worm parasites are required for the homoeostasis of their host and should be excellent targets for chemotherapy of certain parasitic diseases. We show that targeting of Wolbachia spp bacteria in Onchocerca volvulus filariae by doxycycline leads to sterility of adult worms to an extent not seen with drugs used against onchocerciasis, a leading cause of blindness in African countries.
Mesh-terms: Adolescent; Adult; Animals; Anti-Bacterial Agents :: pharmacology; Anti-Bacterial Agents :: therapeutic use; DNA, Bacterial :: analysis; DNA, Helminth :: analysis; Doxycycline :: pharmacology; Doxycycline :: therapeutic use; Female; Human; Male; Middle Aged; Onchocerca volvulus :: genetics; Onchocerca volvulus :: microbiology; Onchocerciasis :: drug therapy; Onchocerciasis :: microbiology; Polymerase Chain Reaction; Support, Non-U.S. Gov't; Symbiosis; Wolbachia :: drug effects; Wolbachia :: genetics; Wolbachia :: physiology;
Bernhard Nocht Institute for Tropical Medicine, 20359, Hamburg, Germany. hoerauf@bni.uni-hamburg.de
Ivermectin is the drug used for mass chemotherapy of onchocerciasis within the WHO African Programme for Onchocerciasis Control. This approach aims to eliminate the disease as a public health problem but using one dose per year may not completely interrupt transmission since it does not suppress microfilaridermia thoroughly enough. Here we show that additional treatment with doxycycline, previously shown to sterilise adult female worms for a few months by depletion of symbiotic wolbachia endobacteria, significantly enhances ivermectin-induced suppression of microfilaridermia, rendering anti-wolbachia treatment a promising basis for blocking transmission by a drug-based approach.
Mesh-terms: Animals; Anti-Bacterial Agents :: administration & dosage; Anti-Bacterial Agents :: therapeutic use; Case-Control Studies; Doxycycline :: administration & dosage; Doxycycline :: therapeutic use; Drug Therapy, Combination; Female; Filaricides :: administration & dosage; Filaricides :: therapeutic use; Human; Ivermectin :: administration & dosage; Ivermectin :: therapeutic use; Onchocerca volvulus :: drug effects; Onchocerca volvulus :: microbiology; Onchocerciasis :: drug therapy; Skin :: pathology; Support, Non-U.S. Gov't; Wolbachia :: drug effects;
N G Langworthy,
A Renz,
U Mackenstedt,
K Henkle-Dührsen,
M B de Bronsvoort,
V N Tanya,
M J Donnelly,
A J Trees
Liverpool School of Tropical Medicine and Faculty of Veterinary Science, University of Liverpool, UK.
Filarial nematodes are important and widespread parasites of animals and humans. We have been using the African bovine parasite Onchocerca ochengi as a chemotherapeutic model for O. volvulus, the causal organism of 'river blindness' in humans, for which there is no safe and effective drug lethal to adult worms. Here we report that the antibiotic, oxytetracycline is macrofilaricidal against O. ochengi. In a controlled trial in Cameroon, all adult worms (as well as microfilariae) were killed, and O. ochengi intradermal nodules resolved, by nine months' post-treatment in cattle treated intermittently for six months. Adult worms removed from concurrent controls remained fully viable and reproductively active. By serial electron-microscopic examination, the macrofilaricidal effects were related to the elimination of intracellular micro-organisms, initially abundant. Analysis of a fragment of the 16S rRNA gene from the O. ochengi micro-organisms confirmed them to be Wolbachia organisms of the order Rickettsiales, and showed that the sequence differed in only one nucleotide in 858 from the homologous sequence of the Wolbachia organisms of O. volvulus. These data are, to our knowledge, the first to show that antibiotic therapy can be lethal to adult filariae. They suggest that tetracycline therapy is likely to be macrofilaricidal against O. volvulus infections in humans and, since similar Wolbachia organisms occur in a number of other filarial nematodes, against those infections too. In that the elimination of Wolbachia preceded the resolution of the filarial infections, they suggest that in O. ochengi at least, the Wolbachia organisms play an essential role in the biology and metabolism of the filarial worm.
Mesh-terms: Animals; Cameroon; Cattle; Female; Human; Male; Onchocerca :: cytology; Onchocerca :: drug effects; Onchocerca :: microbiology; Onchocerciasis :: drug therapy; Onchocerciasis, Ocular :: parasitology; Oxytetracycline :: pharmacology; Oxytetracycline :: therapeutic use; Support, Non-U.S. Gov't; Tetracyclines :: pharmacology; Tetracyclines :: therapeutic use; Wolbachia :: drug effects; Wolbachia :: physiology;
Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, 3000 DR Rotterdam, Netherlands. w.stolk@erasmusmc.nl
BACKGROUND: Wolbachia endosymbionts of filarial nematodes are vital for larval development and adult-worm fertility and viability. This essential dependency on the bacterium for survival of the parasites has provided a new approach to treat filariasis with antibiotics. We used this strategy to investigate the effects of doxycycline treatment on the major cause of lymphatic filariasis, Wuchereria bancrofti. METHODS: We undertook a double-blind, randomised, placebo-controlled field trial of doxycycline (200 mg per day) for 8 weeks in 72 individuals infected with W bancrofti from Kimang'a village, Pangani, Tanzania. Participants were randomly assigned by block randomisation to receive capsules of doxycycline (n=34) or placebo (n=38). We assessed treatment efficacy by monitoring microfilaraemia, antigenaemia, and ultrasound detection of adult worms. Follow-up assessments were done at 5, 8, 11, and 14 months after the start of treatment. Analysis was per protocol. FINDINGS: One person from the doxycycline group died from HIV infection. Five (doxycycline) and 11 (placebo) individuals were absent at the time of ultrasound analysis. Doxycycline treatment almost completely eliminated microfilaraemia at 8-14 months' follow-up (for all timepoints p<0.001). Ultrasonography detected adult worms in only six (22%) of 27 individuals treated with doxycycline compared with 24 (88%) of 27 with placebo at 14 months after the start of treatment (p<0.0001). At the same timepoint, filarial antigenaemia in the doxycycline group fell to about half of that before treatment (p=0.015). Adverse events were few and mild. INTERPRETATION: An 8-week course of doxycycline is a safe and well-tolerated treatment for lymphatic filariasis with significant activity against adult worms and microfilaraemia.
Mesh-terms: Adolescent; Adult; Aged; Animals; Anti-Bacterial Agents :: therapeutic use; Double-Blind Method; Doxycycline :: therapeutic use; Elephantiasis, Filarial :: drug therapy; Elephantiasis, Filarial :: parasitology; Humans; Male; Middle Aged; Research Support, Non-U.S. Gov't; Wolbachia :: drug effects; Wuchereria bancrofti :: drug effects; Wuchereria bancrofti :: microbiology;
Dipartimento di Patologia Animale, Igiene e Sanità Pubblica Veterinaria, Sezione di Patologia, Generale e Parassitologia, Università di Milano, 20133 Milan, Italy.
The presence of intracellular bacteria in the body of various species of filarial nematodes, including important parasites such as Brugia malayi, Dirofilaria immitis, and Onchocerca volvulus, was observed as early as the mid-1970s. These bacteria were shown to be transovarially transmitted (from the female worm to the offspring) and to be present in significant amounts in the body of the nematode. As highlighted by their discoverers, the potential importance of these bacteria is fairly obvious:(1) bacteria-derived molecules should be considered as having an immunological and pathological role in filarial diseases;(2) the interaction between the bacteria and the filarial host deserves investigation, in view of the possibility that the bacteria are needed by the host nematode and could thus represent a target for therapy. Other authors, independently from the discovery of these intracellular bacteria, showed that the antibiotic tetracycline (which is well known for its efficacy on intracellular bacteria) had detrimental effects on two species of filarial nematodes (Brugia pahangi and Litomosoides sigmodontis). It is therefore surprising that for more than 20 years, no further investigations focused on the bacteria of filarial nematodes, nor on the anti-filarial properties of tetracycline. Recently, the bacteria of filarial nematodes have been independently "rediscovered" by research groups from the schools of Hamburg, Liverpool and Milan. These bacteria are now classified as Wolbachia, and the basic aspects of their phylogenetic history and relationship with the Wolbachia of arthropods have been reconstructed. In addition, their implications for the pathogenesis and treatment of filarial diseases have started to be uncovered. This paper, which is authored by representatives of the three European schools who reopened this research area, reviews our present knowledge of these fascinating microorganisms, highlighting the complexity of a symbiotic system which involves, in addition to the nematode and its bacterium, the vertebrate host.
Mesh-terms: Animals; Anthelmintics :: adverse effects; Anthelmintics :: therapeutic use; Anti-Bacterial Agents :: therapeutic use; Antibodies, Bacterial :: analysis; Antibodies, Bacterial :: biosynthesis; Diethylcarbamazine :: adverse effects; Diethylcarbamazine :: therapeutic use; Evolution; Filariasis :: drug therapy; Filariasis :: microbiology; Filariasis :: parasitology; Filarioidea :: microbiology; Human; Phylogeny; Support, Non-U.S. Gov't; Symbiosis; Wolbachia :: drug effects; Wolbachia :: genetics; Wolbachia :: growth & development;
The symbiosis of filarial nematodes and intracellular Wolbachia bacteria has recently been exploited as a target for antibiotic therapy of filariasis. Antibiotic treatment of filarial nematodes results in sterility and inhibits larval development and adult worm viability. In the first trial on human onchocerciasis depletion of bacteria following treatment with doxycycline resulted in a complete and long-term block of embryogenesis. Bacteria are unable to repopulate nematode tissues up to 18 months after depletion, suggesting these effects may be permanent. Following ivermectin treatment, individuals given antibiotic therapy showed sustained reductions in skin microfilariae, with the majority of people remaining microfilarial negative 12-18 months after treatment. Since Wolbachia also contribute to the inflammatory pathogenesis of filarial disease, antibiotic therapy could, in addition to effects on worm fertility or viability, prevent the onset or development of filarial pathology.
Department of Biology, University College London, London NW1 2HE, United Kingdom. g.hurst@galton.ucl.ac.uk
Inherited microorganisms that disturb the reproduction of their host have been characterized from a number of host taxa. To understand the general principles underlying the genetic and mechanistic basis of interactions, study of different agents in model host species is required. To this end, the nature and genetics of the maternally inherited sex-ratio trait of Drosophila bifasciata were investigated. Successful curing of affected lines with antibiotics demonstrated this trait was associated with the presence of a bacterium, and molecular systematic analysis demonstrated an association between the presence of the trait and infection with an A group Wolbachia. The penetrance and heritability of the trait did not vary with maternal age. Exposure to elevated temperatures did reduce trait penetrance but did not affect heritability. Examination of the effect of temperature on bacterial density in eggs revealed a decrease in bacterial density following exposure of the parent to elevated temperature, consistent with the hypothesis that male killing in D. bifasciata requires a threshold density of Wolbachia within eggs. The male offspring produced following exposure to elevated temperatures were infected with Wolbachia on emergence as adults. Crossing studies demonstrated a weak cytoplasmic incompatibility phenotype exhibited by Wolbachia in these males. The results are discussed with respect to the incidence of male killing within the clade Wolbachia, the general nature of Wolbachia-host interactions, and the prospects for using this association to investigate the mechanism of male killing.
Mesh-terms: Animals; Crosses, Genetic; Drosophila :: classification; Drosophila :: genetics; Drosophila :: microbiology; Female; Fertility; Larva; Male; Phenotype; Phylogeny; Rifampin :: pharmacology; Sex Ratio; Support, Non-U.S. Gov't; Temperature; Wolbachia :: drug effects; Wolbachia :: growth & development; Wolbachia :: pathogenicity;
Achim Hoerauf,
Sabine Mand,
Kerstin Fischer,
Thomas Kruppa,
Yeboah Marfo-Debrekyei,
Alexander Yaw Debrah,
Kenneth M Pfarr,
Ohene Adjei,
Dietrich W Büttner
Department of Helminthology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, 20359, Hamburg, Germany, hoerauf@bni.uni-hamburg.de
Chemotherapy of onchocerciasis by doxycycline, which targets symbiotic Wolbachia endobacteria, has been shown to result in a long-term sterility of adult female worms and corresponding absence of microfilariae. It represents an additional chemotherapeutic approach. The aim of this study was to determine whether a similar regimen would also show efficacy against Wuchereria bancrofti. Ghanaian individuals ( n=93) with lymphatic filariasis and a minimum microfilaremia of 40 microfilariae/ml were included in a treatment study consisting of four arms:(1) doxycycline 200 mg/day for 6 weeks;(2) doxycycline as in (1), followed by a single dose of ivermectin after 4 months;(3) ivermectin only; or (4) no treatment during observation period of 1 year (ivermectin at the end of the study). Doxycycline treatment resulted in a 96% loss of Wolbachia, as determined by real time PCR from microfilariae. After 12 months, doxycycline had led to a 99% reduction of microfilaremia when given alone, and to a complete amicrofilaremia together with ivermectin. In contrast, after ivermectin treatment alone a significant presence of microfilariae remained (9% compared to pretreatment), as known from other studies. This study shows that doxycycline is also effective in depleting Wolbachia from W. bancrofti. It is likely that the mechanism of doxycycline is similar to that in other filarial species, i.e., a predominant blockade of embryogenesis, leading to a decline of microfilariae according to their half-life. This could render doxycycline treatment an additional tool for the treatment of microfilaria-associated diseases in bancroftian filariasis, such as tropical pulmonary eosinophilia and microfiluria.
Mesh-terms: Adolescent; Adult; Animals; Anti-Bacterial Agents :: administration & dosage; Anti-Bacterial Agents :: pharmacology; Anti-Bacterial Agents :: therapeutic use; Doxycycline :: administration & dosage; Doxycycline :: pharmacology; Doxycycline :: therapeutic use; Elephantiasis, Filarial :: drug therapy; Elephantiasis, Filarial :: parasitology; Female; Filaricides :: administration & dosage; Filaricides :: pharmacology; Filaricides :: therapeutic use; Ghana; Human; Ivermectin :: administration & dosage; Ivermectin :: pharmacology; Ivermectin :: therapeutic use; Male; Microfilaria :: drug effects; Middle Aged; Parasitemia :: drug therapy; Support, Non-U.S. Gov't; Symbiosis; Wolbachia :: drug effects; Wolbachia :: growth & development; Wuchereria bancrofti :: drug effects; Wuchereria bancrofti :: growth & development; Wuchereria bancrofti :: microbiology;
Tropical Parasitic Diseases Unit, Northwick Park Institute for Medical Research, Harrow, UK. s.townson@ic.ac.uk
The activity against filarial parasites of the antibiotics rifampicin, oxytetracycline and chloramphenicol was examined. In addition, transmission electron microscopy was used to study the effects of rifampicin and oxytetracycline on filarial tissues and on the endosymbiont bacterium, Wolbachia. When tested in vitro at a concentration of 50.0 microM, each of the three antibiotics significantly reduced the motility levels of male Onchocerca gutturosa. Rifampicin, however, was the most active, virtually immobilizing the parasite by the end of the 40-day trial and producing an 84% reduction in viability (as measured by formazan-based colorimetry). In tests against O. lienalis microfilariae (mff) in CBA mice, the numbers of mff recovered after treatment with oxytetracycline at 100, 25 or 6.5 mg/kg daily, for 15 days, were 56%(P < or = 0.03), 38%(P> 0.05) and 45%(P = 0.05) less than that recovered from the untreated controls, respectively. In another trial in mice, rifampicin (100 mg/kg daily for 15 days) was found to be the most active (causing a 74% reduction in the number of mff recovered--approximately equal to that achieved with the positive control of a single dose of ivermectin at 2 microg/kg), with chloramphenicol also showing significant activity (39% reduction). In further, in-vivo trials, at three dose levels (100, 25 or 6.25 mg/kg daily, for 15 days), all three antibiotics were tested against adult Brugia pahangi in the peritoneal cavities of jirds. None of the antibiotics produced a significant reduction in the numbers of live worms recovered, although a marginal effect was observed in eight of the nine antibiotic-treated groups. A further extended trial with rifampicin and oxytetracycline resulted in 43% and 38% reductions in worm recoveries, respectively (not statistically significant but consistent with a marginal effect); some of these worms appeared less motile and qualitatively in poor condition compared with those recovered from untreated jirds. Ultrastructural studies of these treated worms revealed that virtually all of the endosymbiont bacteria had been cleared from the parasite tissues. The tissues of the adult worms appeared to be largely intact but with a granulomatous response of host cells adhering to some specimens. However, developing uterine forms appeared to be abnormal and extensively damaged, showing an abrogation of embryogenesis. In contrast, worms recovered from control animals contained large numbers of Wolbachia, had no adherent host cells, and showed normal ultrastructure; the female worms exhibited a full range of intra-uterine developing stages from eggs to stretched mff. It is likely that the activity of these antibiotics against the endosymbiont Wolbachia causes the observed antifilarial activity, although some direct effect of each drug on filarial viability cannot be ruled out.
Mesh-terms: Animals; Anti-Bacterial Agents :: therapeutic use; Brugia pahangi :: drug effects; Brugia pahangi :: ultrastructure; Cattle; Chloramphenicol :: therapeutic use; Comparative Study; Female; Filariasis :: drug therapy; Gerbillinae; Male; Mice; Mice, Inbred CBA; Microscopy, Electron; Onchocerciasis :: drug therapy; Oxytetracycline :: therapeutic use; Rifampin :: therapeutic use; Support, Non-U.S. Gov't; Treatment Outcome; Wolbachia :: drug effects; Wolbachia :: ultrastructure;
